Premium
Functional Mimicry of a Discontinuous Antigenic Site by a Designed Synthetic Peptide
Author(s) -
Villén Judit,
Borràs Eva,
Schaaper Wim M. M.,
Meloen Rob H.,
Dávila Mercedes,
Domingo Esteban,
Giralt Ernest,
Andreu David
Publication year - 2002
Publication title -
chembiochem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.05
H-Index - 126
eISSN - 1439-7633
pISSN - 1439-4227
DOI - 10.1002/1439-7633(20020301)3:2/3<175::aid-cbic175>3.0.co;2-w
Subject(s) - peptide , biology , molecular mimicry , antigen , virus , polyproline helix , epitope , virology , peptide sequence , chemistry , biochemistry , genetics , gene
Functional reproduction of the discontinuous antigenic site D of foot‐and‐mouth disease virus (FMDV) has been achieved by means of synthetic peptide constructions that integrate each of the three protein loops that define the antigenic site into a single molecule. The site D mimics were designed on the basis of the X‐ray structure of FMDV type C‐S8c1 with the aid of molecular dynamics, so that the five residues assumed to be involved in antigenic recognition are located on the same face of the molecule, exposed to solvent and defining a set of native‐like distances and angles. The designed site D mimics are disulfide‐linked heterodimers that consist of a larger unit containing VP2(71–84), followed by a polyproline module and by VP3(52–62), and a smaller unit corresponding to VP1(188–194) (VP=viral protein). Guinea pig antisera to the peptides recognized the viral particle and competed with site D‐specific monoclonal antibodies, while inoculation with a simple (not covalently joined to one another) admixture of the three VP1–VP3 sequences yielded no detectable virus‐specific serum conversion. Similar results have been reproduced in two bovines. Antisera to the peptides also moderately neutralize FMDV in cell cultures and partially protect guinea pigs against challenge with the virus. These results demonstrate functional mimicry of the discontinuous site D by the peptides, which are therefore obvious candidates for a multicomponent, peptide‐based vaccine against FMDV.